Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 1/2005

01-01-2005 | Original Articles

Carboplatin and tegafur-uracil concomitant with standard radiotherapy in the management of locally advanced head and neck cancer

Authors: Ángel Segura Huerta, Roberto Díaz-Beveridge, José A. Pérez-Fidalgo, Verónica Calderero Aragón, Miguel Pastor Borgoñón, Jorge Aparicio Urtasun, Joaquín Montalar Salcedo

Published in: Clinical and Translational Oncology | Issue 1/2005

Login to get access
Metadata
Title
Carboplatin and tegafur-uracil concomitant with standard radiotherapy in the management of locally advanced head and neck cancer
Authors
Ángel Segura Huerta
Roberto Díaz-Beveridge
José A. Pérez-Fidalgo
Verónica Calderero Aragón
Miguel Pastor Borgoñón
Jorge Aparicio Urtasun
Joaquín Montalar Salcedo
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 1/2005
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02710022

Other articles of this Issue 1/2005

Clinical and Translational Oncology 1/2005 Go to the issue

Case Reports

Chromoendoscopic mucosal resection of a gastric dysplasia

Case Reports

Subacute dementia as presenting feature of carcinomatous leptomeningeal metastases

Original Articles

Prognostic factors including neoadjuvant chemotherapy in Mexican children with neuroblastoma

Original Articles

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node

Educational Review

Paediatric oncology: embryonic tumours

Teaching Section

Rhabdomyosarcoma: present and future perspectives in diagnosis and treatment
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits